SBW/Novamass
Welcome to SBW/Novamass
Background
SBW/Novamass is a part of SBW Corporation performing ADME studies for drug discovery and development companies. SBW/Novamass core competencies are studies on in vitro drug metabolism, CYP related drug-drug interactions and permeation. Besides ADME studies, SBW/Novamass also provides tailor-made problem solving based on LC/MS and NMR techniques (custom analysis) for biopharmaceutical and chemical industry, and natural product analysis.
SBW/Novamass was founded in 2002 and it became part of SBW in 2007.
Mission statement
Our mission is to reduce time-to-market and cost-of-development of drugs by helping our customers • to understand the nature of their lead molecules • to choose competent drug candidates timely and • improving success rate in the development
Providing “M” for ADME
We are the world’s leading expert in drug metabolism. We provide our customers with problem solving intelligence in: • Metabolic profiling • Metabolite identification • Drug interaction studies and • Other ADME* studies
Your benefit from being SBW/Novamass customer
- Study methods optimised specifically for their molecule(s)
- Real drug molecules used as reference compounds in studies
- Superior efficiency and detection sensitivity by UPLC/TOF-MS in metabolite profiling
- Scientifically high quality predictions
- Detailed expert reports and conclusions
- Free consultation for study start-up
- Seamless link with various computational platforms for ADME, bioactivity and toxicity predictions and rational drug design
SBW/Novamass expertise and services
The variety of SBW/Novamass’s world leading expertise and services are presented in this www site. A good starting point is in our ADME/DMPK lead optimization pages.
To existing Novamass customers: the original Novamass www site is no longer active, you can find all the Novamass services and expertise in this site, presenting the whole SBW group. We are happy to help, please contact us form this link (emails, phone number etc.).
